Strategic consulting and international investor and media relations.
We aim to level the playing field for European companies:
Cohesion amplifies impact.
- NEW YORK
- TEL AVIV
What’s in store in 2024?
Biotech investment: is the oncology focus coming at the expense of areas with greater need?
We must reframe the discussion on Alzheimer’s disease
Why are European companies shy of IPOs?
AC Immune Receives FDA Fast Track Designation For Anti-Amyloid-Beta Active Immunotherapy, ACI-24.060, To Treat Alzheimer’s Disease
Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics
To level the playing field for European companies by increasing their engagement with the investment community across Europe and the U.S.
What sets us apart
We are pan-European and trans-Atlantic with deep expertise in strategic advice, investor relations, media relations and business development. Our passion for accelerating growth drives our commitment to help our clients achieve success.
Our core values include integrity, accountability, transparent communication, and a commitment to delivering high-quality work with speed. We prioritize agility, adaptability, and timeliness to drive maximum impact for our clients.